chr19-39243825-T-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_172139.4(IFNL3):āc.491A>Cā(p.Lys164Thr) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,613,568 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_172139.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IFNL3 | NM_172139.4 | c.491A>C | p.Lys164Thr | missense_variant, splice_region_variant | 4/5 | ENST00000413851.3 | NP_742151.2 | |
IFNL3 | NM_001346937.2 | c.503A>C | p.Lys168Thr | missense_variant, splice_region_variant | 5/6 | NP_001333866.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IFNL3 | ENST00000413851.3 | c.491A>C | p.Lys164Thr | missense_variant, splice_region_variant | 4/5 | 1 | NM_172139.4 | ENSP00000409000 | A2 | |
IFNL3 | ENST00000613087.5 | c.503A>C | p.Lys168Thr | missense_variant, splice_region_variant | 5/6 | 1 | ENSP00000481633 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000361 AC: 9AN: 249332Hom.: 0 AF XY: 0.0000370 AC XY: 5AN XY: 135106
GnomAD4 exome AF: 0.0000198 AC: 29AN: 1461366Hom.: 0 Cov.: 33 AF XY: 0.0000206 AC XY: 15AN XY: 726994
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152202Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 27, 2023 | The c.491A>C (p.K164T) alteration is located in exon 4 (coding exon 4) of the IFNL3 gene. This alteration results from a A to C substitution at nucleotide position 491, causing the lysine (K) at amino acid position 164 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at